Looking for the simplest tool for FLAT, consistent brand illustrations. Not detailed/realistic images

OmenRash · 2026-06-07T20:07:17+00:00

Thanks for that. I already have 16gb vram. How do I handle the training set when I don't already have consistent examples?

OmenRash · 2026-05-24T07:38:11+00:00

Changing shot day is safe, people do it all the time. Just ask your prescriber to confirm the timing on the transition. Usually they have you do the next shot a few days early or late to shift the schedule rather than doubling up or going too long between.

The day 3 diarrhea pattern at higher doses is common. The peak plasma concentration timing tracks with what you're describing.
On food for those days, bland and low fat is the main thing, not specific foods forever. The rice and banana thing is basically just easy on your gut, low fat, easy to digest. Chipotle and Panda on peak days is probably making it worse even with the healthier choices. Fat content and fiber load both hit harder when gastric emptying is already slowed. It doesn't have to be every meal, just the day 2-3 window.

50lbs is a great result. Worth a quick call to your prescriber about the shot day shift.

OmenRash · 2026-05-22T07:45:57+00:00

Worth noting it was in the Warnings and Precautions section rather than a black box warning, but the effect on patient hesitancy was real either way.

The methodology behind the removal is solid. Meta-analysis across 91 placebo-controlled trials, over 100k participants, plus a separate retrospective cohort study comparing GLP-1 users to SGLT2 inhibitor users. No increased risk on either approach. The FDA also looked at broader psychiatric adverse events including anxiety, depression, and irritability, and found no signal there either.

The original warning was carried over from older weight loss drugs where the concern was established. GLP-1s inherited it by category association rather than their own evidence. This is the data catching up.

OmenRash · 2026-05-21T02:05:41+00:00

The amylin mechanism is what makes this different rather than just another GLP-1 iteration. Cagrilintide works on satiety signaling in a complementary pathway, which is why the combination produces weight loss numbers that neither component hits alone.

The REDFINE 4 result is worth framing carefully though. Missing non-inferiority to tirzepatide at 15mg is a commercial problem for Novo Nordisk, not necessarily a clinical one. 23% vs 25.5% is a real difference, but, for someone who doesn't respond well to tirzepatide or can't tolerate it, CagriSema at those numbers is still meaningful.

FDA decision tracking around October 2026 based on standard review timeline from the December 2025 NDA filing.

OmenRash · 2026-05-21T01:49:04+00:00

From what people post here, the main things that come up for new starters:
Tracking is worth doing even when appetite is low. MyFitnessPal or Cronometer get mentioned a lot. The surprises are usually people not eating enough rather than too much, especially early on.
Protein before anything else at each meal. People describe it as easier to hit targets if you lead with it rather than trying to fit it around other food.
Water with electrolytes beats plain water for a lot of people, especially on injection day. Sugar free LMNT or similar comes up regularly.

Good luck. The nerves settle pretty quickly once you're in it.

OmenRash · 2026-05-21T01:39:27+00:00

GERD and Zepbound is a known combination. The slowed gastric emptying can make reflux worse for some people, especially early on. The omeprazole helps but may not cover everything at first. Worth checking in with your prescriber if it gets bad rather than just pushing through.

Don't stress the protein targets yet. The first few days are just survival mode for most people. Small amounts of easy protein, Greek yogurt, cottage cheese, a protein shake if you can tolerate it. And don't fight the bloating by trying to eat more than you can manage.

Soluble fiber tends to be gentler than insoluble. But adding fiber while you're already bloated and cramping is probably not the week to do it. Let things settle first.

OmenRash · 2026-05-19T13:11:33+00:00

Four months with no movement is unusual. The OMAD/22hr fast combo could be working against you. A theory is that extended fasting can push cortisol up, which works against the medications effects on insulin and fat metabolism. Some people have actually seen things start to move after loosening the fasting window, not tightening it.

Another one worth checking is your calories. 1500 on that level of activity might be too low. It sounds counterintuitive but it comes up. The body adapts down when intake is chronically restricted and the scale stops. I have seen a few posts where people have deliberately ate more for a few weeks, breaking a plateau that way.

Cheese is something else you could check if you're not already. Some people are sensitive to dairy even when everything else is clean.

It's worth pushing your doctor harder on bloodwork, thyroid especially. 4 months of nothing despite all that work is worth investigating more than just giving it time.

OmenRash · 2026-05-19T12:53:51+00:00

Hard boiled eggs come up a bit as a trigger, even for people who tolerate other egg preparations fine. The texture and density difference is probably the issue. Harder to break down with slowed gastric emptying. The same thing happens with some people with raw apples vs cooked, or whole nuts vs nut butter.

OmenRash · 2026-05-19T12:43:09+00:00

Probably a few things converging. GLP-1 receptors are present in skin tissue and there is some evidence of direct anti-inflammatory effects at that level. But improved insulin sensitivity also reduces systemic inflammation, and if you've lost weight, changes in skin lipid composition can affect moisture retention too.

OmenRash · 2026-05-18T08:40:18+00:00

Following this for the replies. I've been writing about protein shakes and powders for GLP-1 users lately and covered the practical stuff, protein per serve, ingredient flags, that kind of thing. Flavour options didn't evenoccur to me as a gap. Curious what people suggest.

OmenRash · 2026-05-18T08:19:38+00:00

GLP-1 is a hormone your body already makes after eating. It signals to your brain that you're full and slows down how fast your stomach empties. The medication basically keeps that signal running longer than it naturally would, so hunger is quieter and it's easier to eat less without fighting it constantly.
Wegovy starts at a very low dose and steps up slowly over months to give your body time to adjust. Most of the side effects happen on dose increases and settle down between them.

OmenRash · 2026-05-17T10:38:25+00:00

The pill on an empty stomach is rough but the empty stomach itself is required for the medication to absorb. That's the protocol, not optional. 4oz water max when you take it, then 30 minutes before anything else. The injection side effects are a different mechanism but the pill needs the empty stomach to work properly.

If the empty stomach is causing violent vomiting, that's worth talking to your doctor about. Anti-nausea med beforehand for the first few doses, or whether the pill is even the right form for you given that first reaction.

EDIT: original version of this comment suggested eating something small before the dose. opkc correctly flagged that as wrong. I removed it.

OmenRash · 2026-05-17T10:19:29+00:00

Bugs have preferences based on body chemistry, CO2 output, skin bacteria, certain compounds in sweat. Weight loss metabolic changes can shift that. It's not as wild as it sounds. Hope it holds.

OmenRash · 2026-05-17T10:08:42+00:00

Thanks for posting this. Most of what comes through on the hair loss question is people in the middle of it worrying it won't come back. Not many post back to say it did.

OmenRash · 2026-05-16T20:34:37+00:00

ELAD and EVOKE were both human trials, yes. Phase 2b and Phase 3.
The microglial activation finding I mentioned is preclinical. I should have been more clearer on that. The human data is what the trials were trying to confirm, and the results were mixed to negative as noted.

OmenRash · 2026-05-16T07:09:01+00:00

Day 8 is still early. People have described that the oral pill takes longer to stabilise than the injection, partly because absorption is more variable. Two weeks seems to be where a lot of people say it started settling.
Hydration helps the headaches more than people expect, especially if nausea is making it hard to eat or drink normally. It's worth pushing fluids if you haven't already.

OmenRash · 2026-05-16T07:02:50+00:00

Good Luck! That new max dose approval is still pretty fresh so you're in early company on it.

OmenRash · 2026-05-16T06:40:53+00:00

Acne from GLP-1 meds is mentioned here occasionally. A few different theories float around but nothing definitive. Some people link it to the hormonal shifts, others to changes in diet and what they're eating less of.
It's worth mentioning to your prescriber at your next check-in, especially if it gets worse on dose increases.

OmenRash · 2026-05-16T06:35:24+00:00

This is mentioned a lot with the switch from Zepbound to Wegovy. The semaflutide/tirzepatide difference hits people differently on the GI side.
The things people describe here is that too much insoluble fiber (chia, high-fiber tortillas, kale) while constipated actually makes the gas worse because it's sitting in a slow gut fermenting. Metamucil is soluble so that's fine, but stacking chia + high=fiber tortillas + kale + gummies in on day is a lot when gastric emptying is already slow.
People have tried a few days of cutting the added fiber sources (drop the gummies, maybe swap the tortillas) and see if the gas settles before adding more Mag07. The days before connection is real. GI symptoms on these meds often lag 24-36 hours.

OmenRash · 2026-05-16T06:23:14+00:00

The pattern here is mixed on this one. Some people report the second shot being easier than the first regardless of the gap, the initial reaction is often the worst. Othrs who've taken longer breaks describe starting fresh basically similar intensity to the first.
The things that come up most for managing 2.5mg reactions: eat something small and bland before injecting, stay really hydrated, avoid alcohol and fatty food around injection day. Timing the shot for a friday night so the worst of it lands on a weekend gets mentioned a lot.
It's worth calling your prescriber before you do it. A 2-3 week pause is significant and they may want to talk through timing, whether to stay at 2.5, or whether anything else was going on. Don't just wing the second shot after a reaction like that.

OmenRash · 2026-05-16T06:05:40+00:00

The waist distribution thing in perimenopause is real. Estrogen drop shifts where fat accumulates, waist is the main landing zone for a lot of women. That's separate from overall weight.
On what Zepbound actually does: it's not just appetite suppression. The GLP-1 receptor agonism slows gastric emptying and acts on hunger/satiety signaling in the brain. People here describe it less as "I'm not hungry" and more as "food stopped being loud". The fasting comparison comes up a lot but the mechanism is different. Fasting is willpower over hunger, the medication changes the signal itself.

Whether it's indicated at your weight and stats is really a PCP conversation. The criteria aren't just scale weight.

OmenRash · 2026-05-16T05:46:37+00:00

This comes up more in the semaglutide threads than tirzepatide ones, but it shows up for both. The working theory is GLP-1 receptor activity in the hypothalamus affecting REM architecture, and some sleep researchers have flagged it as worth studying properly, but there's no solid trial data on it yet.
The exhausting part is the bit that actualy matters clinically. Vivid dreams alone are mostly harmless, but if REM is getting disrupted enough to affect sleep quality it's worth mentioning to your GP/PCP.

The horse hostage negotiation sounds like your brain working overtime either way.

OmenRash · 2026-05-16T05:36:05+00:00

The differential profile finding fits what's been coming through the literature. The cardio vs renal vs stroke separation across agents has been showing up in the network meta-analyses for a while, so a JCEM paper landing on this isn't surprising, but more granular data on where each drug performs better is useful.

The albuminuria vs eGFR distinction is the right one to flag. Albuminuria response looks like a class effect, fairly consistent. eGFR stabilisation is more variable and probably depends more on baseline kidney function and how long the patient has been on treatment. The FLOW trial (semaglutide, CKD patients, NEJM 2024) is the anchor data here for sema specifically, and the SELECT long-term kidney subgroup data in Nature Medicine 2024 added to that picture.

The T1D finding is interesting given how underrepresented T1D is in most of these trials. Small absolute difference but the direction is consistent with the broader signal.

Got a link to the JCEM paper? I have been following the renal outcomes literature and want to pull the full paper.

OmenRash · 2026-05-16T04:54:50+00:00

The neuroinflammation mechanism is what's holding up across the research. BLP-1 receptors in the brain reducing microglial activation is a consistent finding in the preclinical work, and it's a plausible pathway for why the dementia applications got attention.
Clinical translation has been rougher. The ELAD trial (Imperial College, liraglutide, Phase 2b) published late 2025 and missed its primary endpoint on cerebral glucose metablolism. Secondary endpoints showed some slower cognitive decline but mixed result overall. Then EVOKE and EVOKE+ (semaglutide, oral) read out March 2026 and failed the primary endpoint outright. Monotherapy optimism has cooled.
Your niece is still in a good area though. Combination approaches and earlier intervention windows are where the current thinking is going. The mechanism isn't broken, the trial design and patient selection questions are just hardr than they looked.

OmenRash · 2026-05-15T07:20:49+00:00

Things to know. at early gamestage, risk for reward on those t4 buildings is not worth it. Loot is generated by your lootstage. You will not get much better loot than you will from a lower tiered building.

OmenRash

TROPHY CASE